Cargando…

Clinical evaluation of pulmonary hypertension using patient-reported outcomes: a cross-sectional study

BACKGROUND: Patients with pulmonary hypertension (PH) have progressive and disabling symptoms, as well as a burden of treatments and a difficult clinical evaluation that make health-related quality of life a particularly relevant endpoint in this disease. The objective of the study was to evaluate p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amor-García, Miguel Ángel, Ibáñez-García, Sara, García-González, Xandra, Mombiela, Teresa, Villanueva-Bueno, Cristina, Herranz-Alonso, Ana, Sanjurjo-Sáez, María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852357/ https://www.ncbi.nlm.nih.gov/pubmed/33530979 http://dx.doi.org/10.1186/s12890-021-01416-7

Ejemplares similares

Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale
por: Narrillos-Moraza, Álvaro, et al.
Publicado: (2022)

Features and Functionalities of Smartphone Apps Related to COVID-19: Systematic Search in App Stores and Content Analysis
por: Collado-Borrell, Roberto, et al.
Publicado: (2020)

Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy
por: Ramos-Ruperez, Elena, et al.
Publicado: (2023)

Assessing Apps for Patients with Genitourinary Tumors Using the Mobile Application Rating Scale (MARS): Systematic Search in App Stores and Content Analysis
por: Amor-García, Miguel Ángel, et al.
Publicado: (2020)

Oncology Patient Interest in the Use of New Technologies to Manage Their Disease: Cross-Sectional Survey
por: Collado-Borrell, Roberto, et al.
Publicado: (2018)

A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital
por: Villanueva-Bueno, Cristina, et al.
Publicado: (2022)

Trends in hospital consumption of analgesics after the implementation of a pain performance improvement plan
por: Monje, Beatriz, et al.
Publicado: (2018)

The Biological Bases of Group 2 Pulmonary Hypertension
por: Fernández, Ana I., et al.
Publicado: (2019)

Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene
por: García-González, Xandra, et al.
Publicado: (2018)

Neurohormonal Modulation as a Therapeutic Target in Pulmonary Hypertension
por: García-Lunar, Inés, et al.
Publicado: (2020)

Mobile Health Apps Providing Information on Drugs for Adult Emergency Care: Systematic Search on App Stores and Content Analysis
por: García-Sánchez, Sebastián, et al.
Publicado: (2022)

Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer
por: García-González, Xandra, et al.
Publicado: (2015)

Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022)

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: García-González, Xandra, et al.
Publicado: (2021)

COVID-19 in hospitalised patients in Spain: a cohort study in Madrid
por: Rodriguez-Gonzalez, Carmen Guadalupe, et al.
Publicado: (2021)

DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach
por: Villalvazo, Priscila, et al.
Publicado: (2021)

Persistent Pulmonary Hypertension in Corrected Valvular Heart Disease: Hemodynamic Insights and Long‐Term Survival
por: Bermejo, Javier, et al.
Publicado: (2021)

Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022)

Sex Differences in Pulmonary Hypertension
por: Rodriguez-Arias, Juan José, et al.
Publicado: (2021)

Effect of a Mobile App for the Pharmacotherapeutic Follow-Up of Patients With Cancer on Their Health Outcomes: Quasi-Experimental Study
por: Collado-Borrell, Roberto, et al.
Publicado: (2020)

Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: a multicenter, double-blind, randomized clinical trial
por: Bermejo, Javier, et al.
Publicado: (2018)

Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective
por: Marzal-Alfaro, María Belen, et al.
Publicado: (2021)

Addition of Olive Leaf Extract to a Mixture of Algae and Extra Virgin Olive Oils Decreases Fatty Acid Oxidation and Synergically Attenuates Age-Induced Hypertension, Sarcopenia and Insulin Resistance in Rats
por: González-Hedström, Daniel, et al.
Publicado: (2021)

Resveratrol Prevents Right Ventricle Dysfunction, Calcium Mishandling, and Energetic Failure via SIRT3 Stimulation in Pulmonary Arterial Hypertension
por: Bernal-Ramírez, Judith, et al.
Publicado: (2021)

Transition from post‐capillary pulmonary hypertension to combined pre‐ and post‐capillary pulmonary hypertension in swine: a key role for endothelin
por: van Duin, Richard W. B., et al.
Publicado: (2018)

Adherence to the DASH diet by hypertension status in Mexican men and women: A cross-sectional study
por: Reyes-García, Alan, et al.
Publicado: (2022)

Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey
por: Chamorro-de-Vega, Esther, et al.
Publicado: (2022)

Primary pulmonary synovial sarcoma: a rare neoplasm
por: García, José Soro, et al.
Publicado: (2016)

Design of the β3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial
por: Garcia-Lunar, Ines, et al.
Publicado: (2020)

Evaluation of Pulmonary Hypertension in Dogs with Heartworm Disease Using the Computed Tomographic Pulmonary Trunk to Aorta Diameter Ratio
por: Matos, Jorge Isidoro, et al.
Publicado: (2022)

Reduced pulmonary vascular reserve during stress echocardiography in confirmed pulmonary hypertension and patients at risk of overt pulmonary hypertension
por: Wierzbowska-Drabik, Karina, et al.
Publicado: (2020)

A Cross-sectional Assessment of Health-related Quality of Life among Patients with Chronic Obstructive Pulmonary Disease
por: GARCIA-GORDILLO, Miguel Ángel, et al.
Publicado: (2017)

Effects of Exercise Training on Circulating Biomarkers of Endothelial Function in Pulmonary Arterial Hypertension
por: Rodríguez-Chiaradía, Diego A., et al.
Publicado: (2023)

Metabolic Reprogramming in the Heart and Lung in a Murine Model of Pulmonary Arterial Hypertension
por: Izquierdo-Garcia, Jose L., et al.
Publicado: (2018)

Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension
por: García-Álvarez, Ana, et al.
Publicado: (2016)

Handgrip Strength-Related Factors in a Colombian Hypertensive Population: A Cross-Sectional Study
por: Rivas-Campo, Yulieth, et al.
Publicado: (2022)

Office and 24-hour heart rate and target organ damage in hypertensive patients
por: García-García, Ángel, et al.
Publicado: (2012)

Prolonged stay predictors in patients admitted with chronic obstructive pulmonary disease acute exacerbation
por: García-Sanz, María-Teresa, et al.
Publicado: (2018)

Trends in Hypertension Prevalence, Awareness, Treatment and Control in an Adult Type 2 Diabetes Spanish Population between 2003 and 2009
por: de Burgos-Lunar, Carmen, et al.
Publicado: (2014)

Usefulness of NT-proBNP in dogs with heartworm: could this biomarker be useful to evaluate pulmonary hypertension?
por: Costa-Rodríguez, Noelia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pg6kf97rlsffoofb44snmgueig